Nuclear factor-erythroid 2 p45 (NF-E2 p45)-related factor 2 (Nrf2) is a master regulator of redox homoeostasis that allows cells to adapt to oxidative stress and also promotes cell proliferation. In this review, we describe the molecular mechanisms by which oxidants/electrophilic agents and growth factors increase Nrf2 activity. In the former case, oxidants/electrophiles increase the stability of Nrf2 by antagonizing the ability of Kelch-like ECH-associated protein 1 (Keap1) to target the transcription factor for proteasomal degradation via the cullin-3 (Cul3)–RING ubiquitin ligase CRLKeap1. In the latter case, we speculate that growth factors increase the stability of Nrf2 by stimulating phosphoinositide 3-kinase (PI3K)−protein kinase B (PKB)/Akt signalling, which in turn results in inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) and in doing so prevents the formation of a DSGIS motif-containing phosphodegron in Nrf2 that is recognized by the β-transducin repeat-containing protein (β-TrCP) Cul1-based E3 ubiquitin ligase complex SCFβ-TrCP. We present data showing that in the absence of Keap1, the electrophile tert-butyl hydroquinone (tBHQ) can stimulate Nrf2 activity and induce the Nrf2-target gene NAD(P)H:quinone oxidoreductase-1 (NQO1), whilst simultaneously causing inhibitory phosphorylation of GSK-3β at Ser9. Together, these observations suggest that tBHQ can suppress the ability of SCFβ-TrCP to target Nrf2 for proteasomal degradation by increasing PI3K−PKB/Akt signalling. We also propose a scheme that explains how other protein kinases that inhibit GSK-3 could stimulate induction of Nrf2-target genes by preventing formation of the DSGIS motif-containing phosphodegron in Nrf2.
Skip Nav Destination
Article navigation
August 2015
- Cover Image
- PDF Icon PDF LinkTable of Contents
Review Article|
August 03 2015
Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3
John D. Hayes;
John D. Hayes
1
*Jacqui Wood Cancer Centre, Division of Cancer Research, University of Dundee, Dundee DD1 9SY, Scotland, U.K.
1To whom correspondence should be addressed (emailj.d.hayes@dundee.ac.uk).
Search for other works by this author on:
Sudhir Chowdhry;
Sudhir Chowdhry
*Jacqui Wood Cancer Centre, Division of Cancer Research, University of Dundee, Dundee DD1 9SY, Scotland, U.K.
Search for other works by this author on:
Albena T. Dinkova-Kostova;
Albena T. Dinkova-Kostova
*Jacqui Wood Cancer Centre, Division of Cancer Research, University of Dundee, Dundee DD1 9SY, Scotland, U.K.
Search for other works by this author on:
Calum Sutherland
Calum Sutherland
†Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, U.K.
Search for other works by this author on:
Biochem Soc Trans (2015) 43 (4): 611–620.
Article history
Received:
January 13 2015
Citation
John D. Hayes, Sudhir Chowdhry, Albena T. Dinkova-Kostova, Calum Sutherland; Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3. Biochem Soc Trans 1 August 2015; 43 (4): 611–620. doi: https://doi.org/10.1042/BST20150011
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.